bromopyruvate has been researched along with platinum in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aldrich-Wright, JR; Garbutcheon-Singh, KB; Harper, BW; Myers, S | 1 |
| Ang, WH; Chin, CF; Ho, HK; Li, J; Pastorin, G; Venkatesan, T; Wong, BS; Yoong, SL; Yu, V; Zhou, QL | 1 |
2 other study(ies) available for bromopyruvate and platinum
| Article | Year |
|---|---|
Combination studies of platinum(II)-based metallointercalators with buthionine-S,R-sulfoximine, 3-bromopyruvate, cisplatin or carboplatin.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Buthionine Sulfoximine; Carboplatin; Cell Line; Cell Line, Tumor; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Drug Synergism; Glutathione; Humans; Inhibitory Concentration 50; Molecular Structure; Neoplasms; Organoplatinum Compounds; Platinum; Pyruvates | 2014 |
Enhanced cytotoxicity to cancer cells by mitochondria-targeting MWCNTs containing platinum(IV) prodrug of cisplatin.
Topics: Antineoplastic Agents; Cell Survival; Cisplatin; Drug Delivery Systems; Drug Synergism; Flow Cytometry; Humans; MCF-7 Cells; Membrane Potential, Mitochondrial; Microscopy, Confocal; Microscopy, Electron, Transmission; Mitochondria; Nanotubes, Carbon; Platinum; Prodrugs; Pyruvates; Rhodamines | 2014 |